v3.26.1
18. STOCK OPTION PLAN
6 Months Ended
Jun. 30, 2026
Notes  
18. STOCK OPTION PLAN

18.STOCK OPTION PLAN AND RESTRICTED SHARE AWARDS 

 

On March 27, 2020, the Company adopted an incentive stock option plan (the “Plan”). The Plan allows the Board of Directors of the Company to grant restricted shares and options to acquire shares of common stock of the Company to directors, officers, key employees and consultants. The option price, term and vesting periods are determined at the discretion of the Board of Directors, subject to certain restrictions as required by the policies of Section 422 of the Internal Revenue Code. The Plan is a fixed number plan with a maximum of 208,334 shares of common stock reserved for issuance under the Plan.

 

On September 7, 2024, the Company amended the 2020 Stock Plan to increase the number of shares of common stock of the Corporation available for grant under the plan from 208,334 (as adjusted for the 1 for 3 reverse split) to 500,000. On November 4, 2025, the Company’s shareholders approved the amendment to the 2020 Stock Plan.

 

The table below sets forth share options outstanding as of June 30, 2026.

 

Grant Date

Options Outstanding

 

Exercise Price

Expiration

Vesting

September 1, 2022

4,896

$

21.60

August 31, 2027

Equally over 3 years commencing on first anniversary of grant date

October 15, 2023

42,345

 

38.40

October 14, 2028

Equally over 3 years commencing on first anniversary of grant date

November 1, 2023

10,417

 

38.40

October 31, 2028

3,334 vest immediately, remaining vest equally over 3 years commencing on first anniversary of grant date

November 22, 2024

8,333

 

11.76

November 23, 2027

Equally over 3 years commencing on first anniversary of grant date

 

During the three and six months ended June 30, 2026 and 2025, the Company recorded share-based compensation expense of $606,548 and $230,474, and $694,002 and $309,354, respectively.

 

As of June 30, 2026, the Company had $158,998 of unrecognized share-based compensation costs related to non-vested awards that will be recognized over a weighted average period of 3 years. As of June 30, 2026, 108,324 options have vested, and are exercisable.

 

The following sets forth the outstanding common share options and related activity for the period ended June 30, 2026:

 

 

 

Weighted Average

 

Number of

Exercise Price

 

Options

Per Share

Outstanding as of December 31, 2025

69,449

$  12.00

 

Granted

-

-

 

Exercised

-

-

 

Forfeited

(3,458)

$ 38.40

 

Outstanding as of June 30, 2026

65,991

$   9.48

 

 

 

Grant Date

Restricted Shares

Issue Price

Expiration

Vesting

December 31, 2024

10,417

$8.24

January 2, 2026

Vested on August 8, 2025 by board resolution

January 10, 2025

10,417

$11.12

January 12, 2026

Vested on August 8, 2025 by board resolution

February 28, 2025

10,417

$5.76

March 2, 2026

Vested on August 8, 2025 by board resolution

May 27, 2025

56,250

$6.64

May 29, 2026

Vested on August 8, 2025 by board resolution

November 4, 2025

87,500

$3.35

September 4, 2026

Vesting over 10 months

November 5, 2025

56,250

$3.19

November 5, 2025

Vested at issuance

May 27, 2026

199,500

$2.40

May 27, 2026

Vested at issuance

 

As of the six months ended June 30, 2026, the Company recorded restricted share-based compensation expense of $566,790, as part of general and administrative expenses. As of June 30, 2026, the Company had $87,990 of unrecognized restricted share-based compensation costs related to non-vested awards that will be recognized over a weighted average period of 10 months. As of June 30, 2026, 404,500 restricted shares have vested.